Curium US LLC

Curium US LLC has been granted 36 US utility patents between 2019 and 2025, placing Curium US LLC at rank #8,773 across all assignees tracked by PlainPatent. This portfolio spans 32 distinct Cooperative Patent Classification (CPC) subclasses, averaging 18.9 claims per patent with primary concentration in G21G (CONVERSION OF CHEMICAL ELEMENTS; RADIOACTIVE SOURCES). As a US Corporation, Curium US LLC is one of the more focused assignees in the PatentsView dataset. The composite Innovation Score of 48.3/100 blends portfolio volume, filing velocity, technology breadth, and claim depth into a single comparable measure drawn directly from USPTO PatentsView records.

Filing cadence tells the strategic story. Between 2020 and 2025 the company received 30 grants, compared with 6 in the 2015–2019 window — a +400% shift in five-year velocity. An acceleration of this magnitude signals aggressive R&D investment and expanding technical ambition. The US Corporation classification further shapes interpretation, since corporate, government, and individual filers pursue patents for materially different reasons.

Claim depth and technology breadth together indicate competitive posture. Curium US LLC's 18.9 average claims per patent sits within the typical range for solid legal coverage without excessive prosecution cost, while a multi-domain presence across 32 subclasses balances depth with breadth. Combined with portfolio volume, these signals let analysts, investors, and licensing professionals benchmark Curium US LLC against peers pursuing similar technology classes.